NCT00319059View on ClinicalTrials.gov

The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
AMPDIschemic Tolerance
Interventions
DRUG

systemic administration of 99mTc-HYNIC-Annexin A5

BEHAVIORAL

10 minutes of ischemic handgripping

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Radboud University Medical Center

OTHER

NCT00319059 - The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance | Biotech Hunter | Biotech Hunter